Medtronic wins pain pump case on preemption | Legal News

Medtronic SynchroMed EL pain pump

Medtronic (NYSE:MDT) won another personal injury lawsuit based on the preemption doctrine it helped create in the U.S. Supreme Court’s Riegel v Medtronic decision in 2008.

Preemption holds that patients can’t sue medical device makers in state courts over products that went through the FDA’s most stringent review process, called pre-market approval. But the justices left open a loophole to allow state suits that allege a "parallel claim" that the company in question broke FDA regulations.

In 2000, plaintiff Richard Stengel began using Medtronic’s SynchroMed EL pain pump, an implanted device that delivers medication directly to the spine via an intrathecal catheter. In 2005, Stengel began developing symptoms of paralysis from an inflammation in his spine around the catheter tip. The device and most of the inflammation were removed, "but not in time to prevent the granuloma from rendering Stengel permanently paraplegic," according to court documents.

The FDA approved the first SynchroMed pump in 1998 and later granted approval for the iteration used to treat Stengel. Medtronic recalled that device in 2008.

The U.S. Court of Appeals for the 9th Circuit upheld a lower court’s ruling dismissing Stengel’s case on preemption grounds, but the 3-judge panel’s decision earned a sharp rebuke from a lone dissenter.

"Has Congress or the Supreme Court created such freedom from liability for the manufacturers of such sensitive devices that only in nonexistent cases are the manufacturers subject to suit for damages?" wrote Judge John Noonan, according to court documents. "Are individuals injured by the malfunction of such devices without remedy against the manufacturers of them? That appears to be the conclusion of this court today with its holding that the [Medical Device Act] explicitly preempts and implicitly preempts any state remedy of damages for violation of a state requirement paralleling the MDA."

Judge J. Clifford Wallace, writing for the majority, said the law is clear on the issue of pre-emption.

"We recognize that it may seem harsh to deny compensation to a person who alleges serious injury from a medical device," Wallace wrote. "But such is the direction from the Supreme Court for cases like the one before us. We are required to follow the Court."

Noonan argued that the Stengel’s lawsuit ought to stand because it presents a parallel claim.

"Nothing in the statute prevents provision by a state of ‘a traditional damages remedy’ for violation of ‘state duties’ that parallel the federal requirements," Noonan wrote. "The Stengels have alleged a valid parallel state law cause of action. Arizona law imposes requirements that parallel the requirements under federal law, and Arizona law provides a remedy in damages for the violation of the state requirement."

Medtronic Donna Marquard spokeswoman said the company is pleased that the appeals court’s decision was "consistent with other federal circuit court and Supreme Court rulings that have upheld the doctrine of federal pre-emption for devices which have gone through the rigorous pre-market approval process for medical devices," according to Cronkite News.

"We are disappointed," Stengel lawyer Thomas Cotter told the news site, declining to comment further.

 Bellwether trials near in DePuy ASR lawsuits

The first cases of the roughly 3,500 personal injury lawsuits filed over Johnson & Johnson‘s (NYSE:JNJ) recalled DePuy ASR hip implant are close to going to trial, with lawyers discussing which suits should serve as "bellwether" trials that are representative of the plaintiffs’ claims.

Six plaintiffs in Nevada, Wisconsin, Florida and Utah have successfully petitioned to be excluded from the multi-district litigation. More than 5,000 patients worldwide have sued over the implants, which were recalled in 2010. 
Read more

 BD loses USPTO trademark challenge
Becton Dickinson & Co. (NYSE:BDX) lost its challenge to a ruling from the U.S. Patent and Trademark Office after the U.S. Court of Appeals for the Federal Circuit upheld a USPTO board was right to refuse to register the design of a blood collection tube component as a trademark.
Read more

 Bard loses appeal in row with insurers

A C.R. Bard (NYSE:BCR) insurer won’t have to cover Bard’s costs in a case it lost to Rochester Medical (NSDQ:ROCM) after the U.S. Court of Appeals for the 3rd Circuit upheld a lower court’s ruling for Rochester.
Read more

 Revolutions Medical wins arbitration over RevVac syringe
Revolutions Medical (PINK:RMCP) won an arbitration case against a former consultant, Richard Theriault, after Theriault asserted his Fifth Amendment right against self-incrimination during depositions over Theriault’s claim to the contractual right to produce, manufacture, distribute and sell the RevVac syringe. 
Read more

 Walkwell Int’l sues over yanked reimbursement code
Walkwell International Laboratories Inc. sued Noridian Administrative Services, claiming the insurance claims processor improperly yanked an code for its custom-made ankle support brace.
Read more

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Leave a Reply